Related Experiment Video
Updated: Jul 23, 2025

A Method for Evaluating the Reinforcing Properties of Ethanol in Rats without Water Deprivation, Saccharin Fading or Extended Access Training
Published on: January 29, 2017
Precipitated withdrawal with kratom use following naltrexone administration
Courtney Jarka1, Kelsey Gregoire1
1Clinical Pharmacy Specialist Critical Care, Catholic Health System, Kenmore Mercy Hospital, Kenmore, New York.
Kratom, an herbal supplement, can cause opioid-like effects and dependence. Combining it with naltrexone may trigger severe withdrawal, underscoring the need for comprehensive patient supplement history.
Area of Science:
- Pharmacology
- Toxicology
- Herbal Medicine Research
Background:
- Kratom (Mitragyna speciosa) is an herbal supplement used for pain relief and opioid withdrawal.
- Its metabolites interact with mu-opioid receptors, similar to traditional opiates.
- Potential for dependence and withdrawal symptoms upon discontinuation exists.
Observation:
- Naltrexone, an opioid antagonist, can induce severe withdrawal symptoms.
- This is particularly relevant when patients use opioids or opioid-like substances.
- A case report details naltrexone precipitating withdrawal in an individual with unrevealed chronic kratom consumption.
Findings:
- Undisclosed chronic kratom use can lead to significant drug interactions.
- Naltrexone administration can precipitate abrupt and severe withdrawal symptoms in kratom users.
- This interaction highlights the opioid-like properties of kratom and its metabolites.
Implications:
- Clinicians must thoroughly assess all herbal and over-the-counter supplement use.
- Failure to identify kratom use can lead to adverse drug events and complicate treatment.
- Comprehensive patient history is crucial for safe and effective medication management.
More Related Videos
09:54Combining Laser Capture Microdissection and Microfluidic qPCR to Analyze Transcriptional Profiles of Single Cells: A Systems Biology Approach to Opioid Dependence
Published on: March 8, 2020
09:29Investigating Drivers of Antireward in Addiction Behavior with Anatomically Specific Single-Cell Gene Expression Methods
Published on: August 4, 2022
Related Concept Videos
Drug Dependence
Desensitization and Tachyphylaxis
CNS Depressants: Alcohol and Nicotine
Opioid Analgesics: Synthetic and Semisynthetic Opioids
Drugs for Treatment of Diarrhea-Predominant IBS
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Drug Abuse and Addiction: Pharmacological Phenomena